Interest expense and penalties, net (benefit)/charge recognized
Vertex Pharmaceuticals Interest expense and penalties, net (benefit)/charge recognized remained flat by 0.0% to $3.28M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 131.6%, from -$10.38M to $3.28M. Over 2 years (FY 2023 to FY 2025), Interest expense and penalties, net (benefit)/charge recognized shows a downward trend with a -60.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in expense signals higher potential costs associated with tax disputes or delayed resolution of tax matters.
Detailed definition
Represents the net expense or benefit recognized in the income statement related to interest and penalties on unrecogniz...
Peer comparison
Standard disclosure in the tax footnote regarding the financial impact of tax contingencies.
other_unrecognized_tax_benefits_income_tax_penalties_and_696650Historical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $84.90M | -$41.50M | $13.10M |
| YoY Change | — | -148.9% | +131.6% |
Interest expense and penalties, net (benefit)/charge recognized at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized?
- Vertex Pharmaceuticals (VRTX) reported interest expense and penalties, net (benefit)/charge recognized of $3.28M in Q4 2025.
- How has Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized changed year-over-year?
- Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized increased by 131.6% year-over-year, from -$10.38M to $3.28M.
- What is the long-term trend for Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized has grown at a -60.7% compound annual growth rate (CAGR), from $84.90M to $13.10M.
- What does interest expense and penalties, net (benefit)/charge recognized mean?
- The cost of interest and penalties associated with uncertain tax positions.